NP39726 Generic and Biosimilar Cancer Medicines
In plain English
The notice doesn't say
Who holds it now
Last won by Takeda UK Limited in Jul 2026.
- NP90726m Vedolizumab (Entyvio®)Takeda UK Limited
- HIV MedicinesAmarox Limited, Glenmark Pharmaceuticals Europe Ltd, Lupin Healthcare UK Ltd and 11 more £89.9m
What you're up against
- The last two awards went to different firms: this buyer has changed supplier before.
- 15 different firms won this buyer's 2 awards for this kind of work in 2026.
The notice as published
Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.